paion.com Report : Visit Site

Technical data of the paion.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host paion.com. Currently, hosted in Germany and its service provider is DomainFactory GmbH .

the related websites

mhra.gov.uk cambridgeenglish.org asos.com ticketmaster.co.uk earthworks-jobs.com hse.gov.uk rightmove.co.uk pwc.com royalcaribbean.com tvguide.com senate.gov techradar.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.29 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

de en company about paion history management supervisory board contact germany uk career what does paioneering mean to us? what paioneers can expect job offers information events information request remimazolam sedation & anesthesia market overview procedural sedation (u.s.) general anesthesia (europe) icu sedation product information about remimazolam clinical trials medical information pipeline portfolio overview remimazolam glossary a_z partnering strategy partnering strategy remimazolam strategy licensing projects remimazolam media and investors at a glance general information contact newsroom press releases ad-hoc releases directors' dealings holdings in company information on shares chart & fact sheet analysts capital actions information on cenes acquisition investorcenter financial reports presentations corporate calendar information request corporate governance declaration on corporate governance articles of association declaration of conformity code of conduct annual general meeting 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 our vision is to be the accepted paioneer in sedation and anesthesia; helping advance patient care. prev next company remimazolam media and investors paion is a specialty pharmaceutical company that develops innovative products for sedation and anesthesia including commercialization. learn more about paion our vision our vision is to be the accepted paioneer in sedation and anesthesia; helping advance patient care. paion's strategy & partnering remimazolam paion’s lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate for which paion has completed the clinical development for use in procedural sedation in the u.s. paion's remimazolam h1 2018 teleconference & webcast 08 august 2018 presentation replay news 09/12/2018 press release: paion announces attendance at four upcoming conferences paion announces attendance at four upcoming conferences read more 08/08/2018 paion ag reports financial results for the first half-year of 2018 paion ag reports financial results for the first half-year of... read more 08/08/2018 consolidated financial interim report for the first half year 2018 consolidated financial interim report for the first half-year... read more 03/09/2017 press release: paion ag: change in management board paion ag: change in management board read more 02/28/2017 press release: paion ag announces successful completion of capital increase with... paion ag announces successful completion of capital increase with... read more 02/07/2017 press release: paion ag: capital increase; preliminary, unaudited key group... paion ag: capital increase; preliminary, unaudited key group... read more 12/21/2016 press release: paion announces clinical development progress with remimazolam by... paion announces clinical development progress with remimazolam by... read more 10/19/2016 press release: positive remimazolam phase iii colonoscopy results presented at... positive remimazolam phase iii colonoscopy results presented at... read more 09/22/2016 press release: remimazolam phase iii colonoscopy data to be presented at the... remimazolam phase iii colonoscopy data to be presented at the... read more 09/06/2016 press release: paion announces clinical development progress with remimazolam by... paion announces clinical development progress with remimazolam by... read more 06/29/2016 press release: paion completes private placement in the amount of eur 9.6... paion completes private placement in the amount of eur 9.6... read more 06/19/2016 press release: paion reports positive remimazolam headline data in pivotal u.s.... paion reports positive remimazolam headline data in pivotal u.s.... read more 04/11/2016 press release: paion successfully completes patient recruitment in phase iii... paion successfully completes patient recruitment in phase iii... read more to the newsroom paion chart visit us on linkedin! copyright © paion ag i all rights reserved imprint privacy statement general terms and conditions martinstrasse 10-12 | 52062 aachen | deutschland tel.: +49 241 4453-0 | fax.: +49 241 4453-100 | e-mail: [email protected] -- company about paion + history management supervisory board contact + germany uk career + what does paioneering mean to us? what paioneers can expect job offers information + events information request remimazolam sedation & anesthesia market + overview procedural sedation (u.s.) general anesthesia (europe) icu sedation product information + about remimazolam clinical trials medical information pipeline portfolio + overview remimazolam glossary + a_z partnering strategy + partnering strategy remimazolam strategy licensing projects + remimazolam media and investors at a glance + general information contact newsroom + press releases ad-hoc releases directors' dealings holdings in company information on shares + chart & fact sheet analysts capital actions information on cenes acquisition investorcenter + financial reports presentations corporate calendar information request corporate governance + declaration on corporate governance articles of association declaration of conformity code of conduct annual general meeting + 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

URL analysis for paion.com

https://www.paion.com/media-and-investors/information-on-shares/chart-fact-sheet/
https://www.paion.com/media-and-investors/newsroom/ad-hoc-releases/
https://www.paion.com/media-and-investors/investorcenter/financial-reports/
https://www.paion.com/footernav/privacy-statement/
https://www.paion.com/media-and-investors/corporate-governance/declaration-on-corporate-governance/
https://www.paion.com/media-and-investors/annual-general-meeting/2017/
https://www.paion.com/newsdetails/press-release-paion-ag-change-in-management-board/?tx_news_pi1%5bcontroller%5d=news&tx_news_pi1%5baction%5d=detail&chash=279b9f2c56faa42de64e1cf13d8a4e6c
https://www.paion.com/remimazolam/sedation-anesthesia-market/general-anesthesia-europe/
https://www.paion.com/pipeline/portfolio/overview/
https://www.paion.com/company/about-paion/supervisory-board/
https://www.paion.com/media-and-investors/annual-general-meeting/2010/
https://www.paion.com/media-and-investors/annual-general-meeting/2018/
https://www.paion.com/newsdetails/press-release-positive-remimazolam-phase-iii-colonoscopy-results-presented-at-the-2016-american-college-of-gastroenterology-annual-scientific-meeting/?tx_news_pi1%5bcontroller%5d=news&tx_news_pi1%5baction%5d=detail&chash=6a85f87a990a9b3371ce458065e610a8
https://www.paion.com/media-and-investors/information-on-shares/capital-actions/
https://www.paion.com/media-and-investors/at-a-glance/general-information/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: PAION.COM
Registry Domain ID: 748711419_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.http.net
Registrar URL: http://www.http.net
Updated Date: 2018-01-11T08:55:53Z
Creation Date: 2007-01-10T18:10:37Z
Registry Expiry Date: 2019-01-10T18:10:37Z
Registrar: HTTP.NET INTERNET GMBH
Registrar IANA ID: 976
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +49.24146314115
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.EURIXX.COM
Name Server: NS1.EURIXX.DE
Name Server: NS2.EURIXX.COM
Name Server: NS2.EURIXX.DE
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-05-19T13:17:22Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR HTTP.NET INTERNET GMBH

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =paion.com

  PORT 43

  TYPE domain

DOMAIN

  NAME paion.com

  CHANGED 2018-01-11

  CREATED 2007-01-10

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1.EURIXX.COM 5.61.84.200

  NS1.EURIXX.DE 5.61.84.199

  NS2.EURIXX.COM 5.61.85.200

  NS2.EURIXX.DE 5.61.85.199

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .